lobbying_activities: 748293

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
748293	20be5e13-83c2-4b0e-898a-70c0bb0214c9	Q1	THE PETRIZZO GROUP, INC.	305932	FATE THERAPEUTICS, INC.	2009	first_quarter	MED	Secure federal assistance to advance from basic research to clinical readiness a first generation stem cell medicine to restore hearing, eyesight and bone fractures by using the fundamental biological mechanisms that guide cell fate to develop innovative therapeutics. Fates research and drug development focuses on modulating adult stem cell biology both in vivo and ex vivo to treat disease and improve health.	Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA)	20000		0	0	2009-04-14T08:26:34-04:00